Rise in Number of Drug Development Projects to Propel Demand for CRO Services

CRO services have gradually penetrated the healthcare sector in the past few years. With significant developments in the healthcare sector in terms of research, medications, drug delivery, etc., CROs are increasingly gaining prominence. As healthcare providers continue to recognize the benefits and advantages of consulting and opting for CRO services, the demand for such services is expected to grow at a significant pace during the forecast period (2019-2027). In the past few years, instead of outsourcing the entire project, biotech companies are leaning toward outsourcing part of clinical trials to CROs. In addition, stakeholders in the current contract research organization (CRO) services market are focusing their attention toward catering to niche and customized requirements of clinical trials.

In recent times, CRO services are assisting companies in the early phase development of new drugs and medications. Clinical research, consulting, and laboratory CRO services are increasingly being used by pharmaceutical companies, a factor expected to propel the growth of the contract research organization (CRO) services market during the assessment period. In addition, stakeholders involved in the current contract research organization (CRO) services market are expected to collaborate with each other to formulate open technology standards that are likely to revolutionize the future of clinical trial operations. Due to these factors and positive outlook of the healthcare sector, the global contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027.

contract research organizations services market infographic

To know the scope of our report Get a Sample on Contract Research Organization (CRO) Services Market   

Focus on R&D in Pharmaceuticals Offers Growth Opportunities for Stakeholders

In the past decade, research and development in the pharmaceutical sector has experienced considerable increase. Established companies in the pharmaceutical sector are leaning toward leaner business models wherein dependence on external entities, such as CROs, is high. The significant growth of the biotech sector in the past decade has played an important role in resulting in rise in the number of companies involved in research and drug development. The exponential rise in the number of active and upcoming drug development companies and research projects created a huge window of opportunity for stakeholders involved in the contract research organization (CRO) services market. In the past decade, outsourcing of large or complex aspects of the drug development process has become imperative for the development of new drugs effectively and cost-effectively.

Get a glimpse of the in-depth analysis through our Report Brochure

Although drug developers are increasingly leveraging CROs services, they are continually seeking solutions to address a host of challenges involved with this approach, such as high R&D cost, obtaining access and tracking the operations that are outsourced, and capacity constraints, among others. At present, stakeholders in the contract research organization (CRO) services market are increasingly adapting to the evolving research & development requirements and are expected to manage contracted work in several modalities. The number of outsourced projects in the last decade has transformed the overall structure of the drug development industry.

Adoption of CROs Services to Accelerate Early Phase Drug Development

The lack of horizontal integration in the contract research organization (CRO) services market has largely been responsible for the inefficiencies in the operations and workflows. Furthermore, this has also isolated drug development processes, which has thus, encouraged the formulation of integrated CRO services models. The growing adoption of integrated model across the pharmaceutical sector has played an integral role in improving efficiency and minimizing the make-test cycle. While the horizontal integration model offered significant benefits and efficiencies in the drug development phase, its adoption in the U.S. was relatively slower than European countries such as the U.K. The demand for CROs services for early phase drug development and clinical research is expected to grow in the coming decade, due to a range of factors, including improved efficiency, streamlined management of R&D costs, low risk of repeat studies, accelerated drug development, and lowered operational costs, among others. Apart from offering monetary benefits, integrated contract organization services are likely to simply the supply chain and efficient management of clinical data.

contract research organizations services market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global contract research organization (CRO) services market is expected to grow at an impressive CAGR of ~8% during the forecast period. The growth of the market can be largely attributed to significant rise in the number of drug development projects across the globe. Moreover, biotech and pharmaceutical companies are increasingly relying on CRO services to complete certain steps of the clinical development of drugs, which will create significant demand for CRO services during the forecast period. The outlook for the contract research organization (CRO) services market during the forecast period is positive, owing to the advent of integrated CRO models. Additionally, Stakeholders in the contract research organization (CRO) services market should focus on collaborating with pharmaceutical companies and leverage opportunities in North America and Europe– the two prominent regions in which large-scale drug development projects are being initiated.

Contract Research Organization (CRO) Services Market: Overview

  • The global contract research organization (CRO) Services market was valued at ~US$ 49 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027. The global market is driven by increased spending on research and development by manufacturers, patent expiries of various biologics leading to increase in the number of clinical trials, rising penetration of CROs, and growing focus of market players on conducting clinical trials in emerging markets.
  • Contract research organizations (CROs) are engaged in offering a range of research services on a contract basis to pharmaceutical, medical device, and biotechnology companies
  • Large biopharmaceutical companies have been outsourcing most of their research and development activities in order to shift from fixed costs to variable costs, increase their access to new technological capabilities, and expand their global reach. This is promoting growth of the global contract research organization (CRO) services market.
  • Rising prevalence of cancer globally is a key factor driving the number of clinical trials being conducted. Furthermore, the global number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. 

Contract Research Organization (CRO) Services: Market Segmentation

  • The global contract research organization (CRO) services market has been segmented based on service type, therapeutic indication, end user, and region
  • In terms of service type, the global contract research organization (CRO) services market has been categorized into early phase development, clinical research services, laboratory services, and consulting services. The early phase development segment has been sub-segmented into discovery services, chemistry, and preclinical services. The preclinical services sub-segment has been further divided into toxicology, pharmacokinetics, and others. The clinical research services segment has been sub-classified into phase I, phase II, phase III, and phase IV. The laboratory services segment has been sub-categorized into bioanalytical services, analytical services, and others.
  • Based on therapeutic indication, the global contract research organization (CRO) services market has been segregated into oncology, infectious diseases, immunological diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others
  • Based on end user, the global contract research organization (CRO) services market has been divided into medical device companies, biopharmaceutical companies, and others 

Contract Research Organization (CRO) Services Market: Regional Segmentation

  • In terms of region, the global contract research organization (CRO) services market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global contract research organization (CRO) services market in 2018 and the trend is expected to continue throughout the forecast period
  • The contract research organization (CRO) services market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Japan is one of the largest industries for clinical trials in Asia Pacific and it witnesses significant product registrations. Large-sized CROs operating worldwide are focused on expanding their presence in Japan through investments in facilities and resources in functional services such as central laboratories, imaging, and clinical supplies. 

Contract Research Organization (CRO) Services Market: Major Players

  • Key players operating in the global contract research organization (CRO) services market are
    • Laboratory Corporation of America Holdings
    • IQVIA Inc.
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences, Inc.
    • PPD, Inc.
    • Charles River Laboratories, Inc.
    • Icon plc
    • WuXi AppTec Group
    • Medpace
  • These players are focused on adopting inorganic growth strategies to strengthen their product portfolio. These companies have adopted strategies such as partnerships and acquisitions to strengthen their market position, expand their portfolio of services, and expand their geographical presence. 

Contract Research Organization (CRO) Services Market - Scope of the Report

TMR’s report on the global contract research organization (CRO) services market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period i.e. from 2019 to 2027. The report provides the overall revenue of the global contract research organization (CRO) services market for the 2017–2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global contract research organization (CRO) services market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global contract research organization (CRO) services market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global contract research organization (CRO) services market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global contract research organization (CRO) services market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global contract research organization (CRO) services market. The next section of the report highlights the USPs, which include regulatory scenarios for contract research organization (CRO) services globally, business models, pricing analysis, and market developments in the global contract research organization (CRO) services market.

The report delves into the competition landscape of the global contract research organization (CRO) services market. Key players operating in the global contract research organization (CRO) services market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global contract research organization (CRO) services market report.

Key Questions Answered in Contract Research Organization (CRO) Services Market Report

  • How much sales revenue would be generated by CRO services across all regions during the forecast period?
  • What are key trends in the global contract research organization (CRO) services market?
  • What are major drivers, restraints, and opportunities in the global contract research organization (CRO) services market?
  • Which regional market is set to expand at the most rapid CAGR during the forecast period?
  • Which segment would generate the maximum revenue by 2027 and which service type segment would expand at the most rapid CAGR during the forecast period?

Contract Research Organization (CRO) Services Market - Research Objectives and Research Approach

The comprehensive report on the global contract research organization (CRO) services market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global contract research organization (CRO) services market. It is followed by market introduction, market dynamics, and an overview of the global contract research organization (CRO) services market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global contract research organization (CRO) services market report highlights the USPs, which include regulatory scenarios for contract research organization (CRO) services globally, market value chain analysis, and developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players in the contract research organization (CRO) services market has been mapped to ascertain the size of the global contract research organization (CRO) services market, in terms of value. The forecast presented here assesses the total revenue generated in the global contract research organization (CRO) services market. In order to provide an accurate forecast, we initiated by sizing up the current contract research organization (CRO) services market with the help of the parent market.

The report analyzes the global contract research organization (CRO) services market in terms of service type, therapeutic indication, and end user. Key segments under each criteria have been studied at length and the market share for each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global contract research organization (CRO) services market.

Contract Research Organization (CRO) Services Market – Segmentation

Service Type

Early Phase Development

  • Discovery Services
  • Chemistry
  • Preclinical Services
    • Toxicology
    • Pharmacokinetics
    • Others

Clinical Research Services

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Laboratory Services

  • Bioanalytical Services
  • Analytical Services
  • Others

Consulting Services

Therapeutic Indication

Oncology

Infectious Diseases

Immunological Disorders

Respiratory Diseases

Cardiovascular Diseases

Neurological Disorders

Others

End User

Medical Device Companies

Biopharmaceutical Companies

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Contract Research Organizations Services Market

Buy Now